Does adenosine deaminase inhibition protect ischemic myocardium?
Gallagher
K P
KP
Parke-Davis Pharmaceutical Division, Warner Lambert Co., Ann Arbor, MI 48105, USA.
McClanahan
T B
TB
Martin
B J
BJ
Saganek
L J
LJ
Ignasiak
D P
DP
Mertz
T E
TE
Van Wylen
D G
DG
Vinten-Johansen
J
J
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology*; D015649:Pentostatin / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits
D058892:Adenosine Deaminase Inhibitors; D004791:Enzyme Inhibitors; D015649:Pentostatin; C010192:9-(2-hydroxy-3-nonyl)adenine; D000225:Adenine